General information about company

Name of The CompanyIpca Laboratories Limited
BSE Scrip Code524494
NSE SymbolIPCALAB
MSE SymbolNOTLISTED
Date of Start of Financial Year01-04-2021
Date of End of Financial Year31-03-2022
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2021
Date of End of Reporting Period30-09-2021
Level of rounding used in financial resultsCrores
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



Related party transactions

A. Details of related party

Sr12345678910111213141516
Name of the related partyKREBS BIOCHEMICALS & INDUSTRIES LTD.TROPHIC WELLNESS PVT.LTD. (Till June 10,2021)AVIK PHARMACEUTICAL LTD.MAKERS LABORATORIES LTD.NIPRA INDUSTRIES PVT. LTD. VANDHARA RESORTS PVT. LTD.PRABHAT FOUNDATIONIPCA FOUNDATIONMR. PREMCHAND GODHAMR. AJIT KUMAR JAINMR.PRANAY GODHAMR. PRASHANT GODHAMR. ANAND T KUSREMR. DEV PRAKASH YADAVAMRS. MANISHA PREMNATHMR. KAMAL KISHORE SETH
Categories of related partiesAssociatesAssociatesJoint ventures where entity is venturerOther related partyOther related partyOther related partyOther related partyOther related partyKey management personnel of entity or parentKey management personnel of entity or parentKey management personnel of entity or parentKey management personnel of entity or parentKey management personnel of entity or parentKey management personnel of entity or parentKey management personnel of entity or parentKey management personnel of entity or parent
description of relationshipAssociatesAssociatesAssociatesEntities in which directors or their relatives have significant InfluenceEntities in which directors or their relatives have significant InfluenceEntities in which directors or their relatives have significant InfluenceEntities in which directors or their relatives have significant InfluenceEntities in which directors or their relatives have significant InfluenceChairman & Managing DirectorJoint Managing Director & CFOExecutive DirectorExecutive DirectorIndependent DirectorIndependent DirectorIndependent DirectorIndependent Director
PAN of related partyAAACK8355MAADCT5576GAAACA5490RAAACM8382JAAACN9372KAAACV1569NAAATP3163HAAGCI1486BAFDPG6492EAADPJ2602AAEMPG2714FAFFPG4317NAACPK9130DAAAPY0846JALSPM0843JAAPPS5211A
CIN of related partyL24110AP1991PLC103912U24100MH2010PTC206526U99999MH1979PLC021711L24230MH1984PLC033389U36900DN1999PTC000142U15200MH1986PTC041780

B. Details of related party transactions

Purchase of goods and services20.3913.861.881.250.01
Sale of goods and services6.155.750.73
Purchase of fixed assets
Sale of fixed assets
Rendering of services0.24
Receiving of services1.47.48
Leases 0.6
Loans and advances given22.951.75
Loans and advances taken
Loans and advances given that are repaid9.5
Loans and advances taken that are repaid
Deposits placed
Deposits taken
Transfer of research & development
Transfers under lease agreement
Equity investment16.68
Impairment in equity investment
Expense for bad or doubtful debts
Guarantees or collateral given11
Guarantees or collateral taken
Interest income2.850.79
Interest paid
Dividend income
Dividend paid
Management contracts including for deputation of employees
Settlement of liabilities by entity on behalf of related party

Remuneration

Short term employee benefits5.053.362.291.59
Post employment benefits0.220.30.120.08
Other long-term benefits
Termination benefits
Share based payments
Others0.250.360.050.060.070.05

C. Outstanding balances

Receivables

Secured
Un Secured19.870.030.910.710.34

Payables

Secured
Un Secured

Loans and advances given

Secured
Un Secured79.9314.18

Loans and advances taken

Secured
Un Secured

Deposits placed

Secured
Un Secured45

Deposits taken

Secured
Un Secured

Guarantees or collateral given

Secured
Un Secured11

Guarantees or collateral taken

Secured
Un Secured

Investment in equity

Secured
Un Secured

Provision for doubtful debt

Secured
Un Secured

Note